Keith Speights

Keith Speights

TMFFishBiz

Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles











Why Tilray Is Sinking Today

Insiders were able to sell their shares for the first time on Tuesday. And their selling took a toll on Tilray's share price.



3 Great Stocks Under $10

It's not the low share price that makes these stocks attractive, it's their huge growth prospects.